Recarbrio

Cilastatin,

Imipenem Anhydrous,

Relebactam Anhydrous

6.6 Moderate risk

Recarbrio & Off label use

100.0%

of users reported Off label use

80.0%

also reported Severe reaction

85.7%

are men

Most common medical consequences

Severe reaction
80.0%
Death
20.0%

Have you experienced any negative side effects from this medication?

Recarbrio: general information

Most common side effects (1)